Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666211 · ClinicalTrials.gov registry record · Phase 3
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
A Phase 3 study of Pain and Lymphoma, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 98
- Enrollment target
- 11
- Study locations
NCT00666211 is a Phase 3 study of Pain and Lymphoma that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 98 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (68% lower). The trial reports 11 study locations across 2 states.
The verdict
NCT00666211, a Phase 3 study of Pain and Lymphoma, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 98 participants
- Enrollment target
- 11
- Study locations
Study Summary
RATIONALE: An Opioid Titration Order Sheet that allows healthcare providers to adjust the dose and schedule of pain medication may help improve pain treatment for patients with cancer. It is not yet known whether the use of an Opioid Titration Order Sheet is more effective than standard care in treating pain caused by cancer. PURPOSE: This randomized phase III trial is studying an Opioid Titration Order Sheet to see how well it works compared with standard care in treating patients with cancer pain.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
- OTHER Titrated pain management
Study Locations (11)
Tennessee
- Erlanger Health System - Chattanooga
- Tennessee Plateau Oncology - Crossville
- Center for Biomedical Research - Knoxville
- The Jones Clinic - Memphis
- Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
- Vanderbilt-Ingram Cancer Center at Franklin - Nashville
- Meharry Medical College - Nashville
- Veterans Affairs Medical Center - Nashville - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Kentucky
- Jennie Stuart Medical Center - Hopkinsville
- Mitchell Memorial Cancer Center at Owensboro Medical Health System - Owensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666211
The ClinicalTrials.gov registry entry for NCT00666211 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (68% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00666211 reports 11 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Kentucky.
Frequently Asked Questions
What is clinical trial NCT00666211 about?
NCT00666211 is a clinical study titled "Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain". RATIONALE: An Opioid Titration Order Sheet that allows healthcare providers to adjust the dose and schedule of pain medication may help improve pain treatment for patients with cancer. It is not yet known whether the use of an Opioid Titration Order Sheet is more effective than standard care in trea...
What is the current status of trial NCT00666211?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2005-05. Estimated completion is 2010-05.
What conditions does trial NCT00666211 study?
This clinical trial studies the following conditions: Pain, Lymphoma, Leukemia, Myelodysplastic Syndromes, Brain and Central Nervous System Tumors.
What interventions are being tested in trial NCT00666211?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER), Titrated pain management (OTHER).
Who is sponsoring clinical trial NCT00666211?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00666211 being conducted?
This trial has 11 study locations across Kentucky, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.